News

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before ...
Government signs deal to see huge investment in mRNA vaccine manufacturing which could help tackle the next pandemic and ...
Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace ...
A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, ...
Coupled with AI-driven design and optimization, researchers can now rapidly fine-tune mRNA structures for improved stability and efficacy. These advancements have propelled mRNA technology forward, ...
BioNTech will invest up to £1bn in UK life sciences over 10 years, launching new AI and R&D centres in London and Cambridge.
IntroductionThe global vaccines market has witnessed unprecedented growth in recent years, driven by technological ...
Clarivate Plc (NYSE:CLVT) launched RiskMark, an AI-driven trademark risk evaluation tool combining CompuMark trademark data ...